Jorge Zagaceta
- Development and validation of a new comorbidity index for COPDBy Miguel Divo, Claudia Cote, Juan Pablo De Torres, Ciro Casanova, Jose Maria Marin, Victor Pinto-Plata, Javier Zulueta, Carlos Cabrera, Jorge Zagaceta and Bartolome CelliMiguel Divo1Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, MA, United StatesClaudia Cote4Pulmonary and Critical Care, Bay Pines Veterans Affairs Medical Center, Bay Pines, FL, United StatesJuan Pablo De Torres2Pulmonary Medicine, Clinica Universitaria/Universidad de Navarra, Pamplona, SpainCiro Casanova6Pulmonary Medicine, Hospital Nuestra Senora de la Candelaria, Tenerife, SpainJose Maria Marin5Pulmonary Medicine, Hospital Miguel Servet, Zaragoza, SpainVictor Pinto-Plata3Pulmonary and Critical Care, St. Elizabeth's Medical Center, Boston, MA, United StatesJavier Zulueta2Pulmonary Medicine, Clinica Universitaria/Universidad de Navarra, Pamplona, SpainCarlos Cabrera7Pulmonary Medicine, Hospital Universitario de Gran Canaria Dr. Negrín, Palmas de Gran Canaria, SpainJorge Zagaceta2Pulmonary Medicine, Clinica Universitaria/Universidad de Navarra, Pamplona, SpainBartolome Celli1Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, MA, United States
- The impact of comorbidities related to BMI in COPD patientsBy Carlos Cabrera Lopez, Jorge Zagaceta, Claudia Cote, Miguel Divo, Juan Pablo De Torres, José María Marín, Ciro Casanova, Victor Pinto-Plata, Javier Zulueta, Bartolomé Celli and Santiago CarrizoCarlos Cabrera Lopez1Pulmonary Medicine, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de G.C., Canarias, SpainJorge Zagaceta2Pulmonary Medicine, Clínica de Navarra/Universidad de Navarra, Pamplona, Navarra, SpainClaudia Cote3Pulmonary and Critical Care Medicine, Bay Pines Veterans Affairs Medical Center, Tampa, FL, United StatesMiguel Divo4Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United StatesJuan Pablo De Torres2Pulmonary Medicine, Clínica de Navarra/Universidad de Navarra, Pamplona, Navarra, SpainJosé María Marín6Pulmonary Medicine, Hospital Nuestra Senora de la Candelaria, Santa Cruz de Tenerife, Canarias, SpainCiro Casanova7Pulmonary and Critical Care Medicine, St. Elizabeth's Medical Center, Boston, MA, United StatesVictor Pinto-Plata7Pulmonary and Critical Care Medicine, St. Elizabeth's Medical Center, Boston, MA, United StatesJavier Zulueta2Pulmonary Medicine, Clínica de Navarra/Universidad de Navarra, Pamplona, Navarra, SpainBartolomé Celli4Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United StatesSantiago Carrizo2Pulmonary Medicine, Clínica de Navarra/Universidad de Navarra, Pamplona, Navarra, Spain
- Massive acute gases intoxication: Clinical presentation and outcomesBy María Sánchez-Carpintero Abad, Ana Belén Alcaide, Aranzazu Campo, Jorge Zagaceta, Felipe Lucena, Manuel Landecho, Félix Alegre, Luis Seijo, Juan Pablo de Torres and Javier ZuluetaMaría Sánchez-Carpintero Abad1Pulmonology, Clínica Universidad de Navarra, Pamplona, Navarra, SpainAna Belén Alcaide1Pulmonology, Clínica Universidad de Navarra, Pamplona, Navarra, SpainAranzazu Campo1Pulmonology, Clínica Universidad de Navarra, Pamplona, Navarra, SpainJorge Zagaceta1Pulmonology, Clínica Universidad de Navarra, Pamplona, Navarra, SpainFelipe Lucena2Internal Medicine, Clínica Universidad de Navarra, Pamplona, Navarra, SpainManuel Landecho2Internal Medicine, Clínica Universidad de Navarra, Pamplona, Navarra, SpainFélix Alegre2Internal Medicine, Clínica Universidad de Navarra, Pamplona, Navarra, SpainLuis Seijo1Pulmonology, Clínica Universidad de Navarra, Pamplona, Navarra, SpainJuan Pablo de Torres1Pulmonology, Clínica Universidad de Navarra, Pamplona, Navarra, SpainJavier Zulueta1Pulmonology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain
- Disease progression in young patients with COPD: rethinking the Fletcher and Peto modelBy Pablo Sanchez-Salcedo, Miguel Divo, Ciro Casanova, Victor Pinto-Plata, Juan P. de-Torres, Claudia Cote, Carlos Cabrera, Jorge Zagaceta, Roberto Rodriguez-Roisin, Javier J. Zulueta, Jose Maria Marin and Bartolome CelliPablo Sanchez-Salcedo1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainMiguel Divo2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USACiro Casanova3Pulmonary Dept, Hospital Universitario La Candelaria, Tenerife, SpainVictor Pinto-Plata2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USAJuan P. de-Torres1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainClaudia Cote4Bay Pines VA Health Care System, St Petersburg, FL, USACarlos Cabrera5Pulmonary Dept, Hospital Universitario Dr Negrín, Las Palmas de Gran Canaria, SpainJorge Zagaceta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainRoberto Rodriguez-Roisin6Pulmonary Dept, Hospital Clínic-IDIBAPS-CIBERES, Barcelona, SpainJavier J. Zulueta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainJose Maria Marin7Pulmonary Dept, Hospital Miguel Servet, Zaragoza, SpainBartolome Celli2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USA
- Emphysema, COPD and lung cancer screening. Update of an ongoing studyBy Pablo Sanchez Salcedo, Maria Sanchez-Carpintero, Juan Bertó, Pilar Rivera, Ana Belén Alcaide, Juan Pablo de Torres, Arantxa Campo, Jorge Zagaceta and Javier ZuluetaPablo Sanchez Salcedo1Neumología, Clinica Universidad de Navarra, Pamplona, Navarra, SpainMaria Sanchez-Carpintero1Neumología, Clinica Universidad de Navarra, Pamplona, Navarra, SpainJuan Bertó1Neumología, Clinica Universidad de Navarra, Pamplona, Navarra, SpainPilar Rivera1Neumología, Clinica Universidad de Navarra, Pamplona, Navarra, SpainAna Belén Alcaide1Neumología, Clinica Universidad de Navarra, Pamplona, Navarra, SpainJuan Pablo de Torres1Neumología, Clinica Universidad de Navarra, Pamplona, Navarra, SpainArantxa Campo1Neumología, Clinica Universidad de Navarra, Pamplona, Navarra, SpainJorge Zagaceta1Neumología, Clinica Universidad de Navarra, Pamplona, Navarra, SpainJavier Zulueta1Neumología, Clinica Universidad de Navarra, Pamplona, Navarra, Spain
- Coronary calcium and epicardial adipose tissue in patients with chronic obstructive pulmonary diseaseBy Jorge Zagaceta, Javier Zulueta, Gorka Bastarrika, Inmaculada Colina, Ana B. Alcaide, Arantza Campo, Bartolome Celli and Juan P. de TorresJorge Zagaceta1Pulmonary, Clínica Universidad De Navarra, Pamplona, Navarra, SpainJavier Zulueta1Pulmonary, Clínica Universidad De Navarra, Pamplona, Navarra, SpainGorka Bastarrika2Radiology, Clínica Universidad De Navarra, Pamplona, Navarra, SpainInmaculada Colina3Internal Medicine, Clínica Univeridad De Navarra, Pamplona, Navarra, SpainAna B. Alcaide1Pulmonary, Clínica Universidad De Navarra, Pamplona, Navarra, SpainArantza Campo1Pulmonary, Clínica Universidad De Navarra, Pamplona, Navarra, SpainBartolome Celli4Pulmonary and Critical Care Medicine, Brigham and Women´s Hospital, Boston, MA, United StatesJuan P. de Torres1Pulmonary, Clínica Universidad De Navarra, Pamplona, Navarra, Spain
- Accelerated lung function decline increases the risk of lung cancerBy Pablo Sanchez, Juan P. de-Torres, Juan Bertó, Pilar Rivera, Arantzazu Campo, Jorge Zagaceta, Ana B. Alcaide and Javier ZuluetaPablo Sanchez1Pulmonology, Clinica Universidad De Navarra, Pamplona, SpainJuan P. de-Torres1Pulmonology, Clinica Universidad De Navarra, Pamplona, SpainJuan Bertó1Pulmonology, Clinica Universidad De Navarra, Pamplona, SpainPilar Rivera1Pulmonology, Clinica Universidad De Navarra, Pamplona, SpainArantzazu Campo1Pulmonology, Clinica Universidad De Navarra, Pamplona, SpainJorge Zagaceta1Pulmonology, Clinica Universidad De Navarra, Pamplona, SpainAna B. Alcaide1Pulmonology, Clinica Universidad De Navarra, Pamplona, SpainJavier Zulueta1Pulmonology, Clinica Universidad De Navarra, Pamplona, Spain
- COPD Comorbidity Network: Connecting the dotsBy Miguel Divo, Victor Pinto-Plata, Carlos Cabrera Lopez, Ciro Casanova, Jorge Zagaceta, Juan Pablo De Torres, Jose Maria Marin, Javier Zulueta, Pablo Sanchez Salcedo, Claudia Cote and Bartolome CelliMiguel Divo1Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, MA, United StatesVictor Pinto-Plata1Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, MA, United StatesCarlos Cabrera Lopez2Pulmonary Medicine, Hospital Universitario Insular De Gran Canaria, Palmas de Gran Canaria, Canary Island, SpainCiro Casanova3Pulmonary Medicine, Hospital Nuestra Senora De La Candelaria, Tenerife, Canary Island, SpainJorge Zagaceta4Pulmonary Medicine, Clinica Universitaria/Universidad De Navarra, Pamplona, SpainJuan Pablo De Torres4Pulmonary Medicine, Clinica Universitaria/Universidad De Navarra, Pamplona, SpainJose Maria Marin5Pulmonary Medicine, Hospital Miguel Servet, Zaragoza, SpainJavier Zulueta4Pulmonary Medicine, Clinica Universitaria/Universidad De Navarra, Pamplona, SpainPablo Sanchez Salcedo4Pulmonary Medicine, Clinica Universitaria/Universidad De Navarra, Pamplona, SpainClaudia Cote6Pulmonary and Critical Care, Bay Pines Veterans Affairs Medical Center, Bay Pines, FL, United StatesBartolome Celli1Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, MA, United States
- Exploring the association betwen active hormonal life and the presence of emphysema/airway obstruction in female smokersBy Juan Berto Botella, Juan Pablo De Torres, Javier Zulueta, Arantzazu Campo, Ana Belén Alcaide, Jorge Zagaceta, Pablo Sánchez, Pilar Rivero and Esmeralda Lopez ZalduendoJuan Berto Botella1Pulmonology, Clinica Universidad Navarra, Pamplona, Navarra, SpainJuan Pablo De Torres1Pulmonology, Clinica Universidad Navarra, Pamplona, Navarra, SpainJavier Zulueta1Pulmonology, Clinica Universidad Navarra, Pamplona, Navarra, SpainArantzazu Campo1Pulmonology, Clinica Universidad Navarra, Pamplona, Navarra, SpainAna Belén Alcaide1Pulmonology, Clinica Universidad Navarra, Pamplona, Navarra, SpainJorge Zagaceta1Pulmonology, Clinica Universidad Navarra, Pamplona, Navarra, SpainPablo Sánchez1Pulmonology, Clinica Universidad Navarra, Pamplona, Navarra, SpainPilar Rivero1Pulmonology, Clinica Universidad Navarra, Pamplona, Navarra, SpainEsmeralda Lopez Zalduendo1Pulmonology, Clinica Universidad Navarra, Pamplona, Navarra, Spain
- Disease progression in young patients with COPD: rethinking the Fletcher and Peto modelBy Pablo Sanchez-Salcedo, Miguel Divo, Ciro Casanova, Victor Pinto-Plata, Juan P. de-Torres, Claudia Cote, Carlos Cabrera, Jorge Zagaceta, Roberto Rodriguez-Roisin, Javier J. Zulueta, Jose Maria Marin and Bartolome CelliArticle | Published in 2014 in European Respiratory JournalPablo Sanchez-Salcedo1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainMiguel Divo2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USACiro Casanova3Pulmonary Dept, Hospital Universitario La Candelaria, Tenerife, SpainVictor Pinto-Plata2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USAJuan P. de-Torres1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainClaudia Cote4Bay Pines VA Health Care System, St Petersburg, FL, USACarlos Cabrera5Pulmonary Dept, Hospital Universitario Dr Negrín, Las Palmas de Gran Canaria, SpainJorge Zagaceta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainRoberto Rodriguez-Roisin6Pulmonary Dept, Hospital Clinic, Barcelona, SpainJavier J. Zulueta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainJose Maria Marin7Pulmonary Dept, Hospital Miguel Servet, Zaragoza, SpainBartolome Celli2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USA
- Disease progression in young patients with COPD: rethinking the Fletcher and Peto modelBy Pablo Sanchez-Salcedo, Miguel Divo, Ciro Casanova, Victor Pinto-Plata, Juan P. de-Torres, Claudia Cote, Carlos Cabrera, Jorge Zagaceta, Roberto Rodriguez-Roisin, Javier J. Zulueta, Jose Maria Marin and Bartolome CelliArticle | Published in 2014 in European Respiratory JournalPablo Sanchez-Salcedo1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainMiguel Divo2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USACiro Casanova3Pulmonary Dept, Hospital Universitario La Candelaria, Tenerife, SpainVictor Pinto-Plata2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USAJuan P. de-Torres1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainClaudia Cote4Bay Pines VA Health Care System, St Petersburg, FL, USACarlos Cabrera5Pulmonary Dept, Hospital Universitario Dr Negrín, Las Palmas de Gran Canaria, SpainJorge Zagaceta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainRoberto Rodriguez-Roisin6Pulmonary Dept, Hospital Clinic, Barcelona, SpainJavier J. Zulueta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainJose Maria Marin7Pulmonary Dept, Hospital Miguel Servet, Zaragoza, SpainBartolome Celli2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USA
- Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV eventsBy Jorge Zagaceta, Javier Zulueta, Gorka Bastarrika, Inmaculada Colina, Arantza Campo, Ana Belen Alcaide, Pablo Sánchez, Juan Bertó, Pilar Rivera, Bartolome Celli and Juan Pablo de TorresJorge Zagaceta1Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Navarra, SpainJavier Zulueta1Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Navarra, SpainGorka Bastarrika2Radiology Department, Clínica Universidad de Navarra, Pamplona, Navarra, SpainInmaculada Colina3Internal Medicine Department, Clínica Universidad de Navarra, Pamplona, Navarra, SpainArantza Campo1Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Navarra, SpainAna Belen Alcaide1Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Navarra, SpainPablo Sánchez1Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Navarra, SpainJuan Bertó1Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Navarra, SpainPilar Rivera1Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Navarra, SpainBartolome Celli4Pulmonary Division, Brigham and Women´s Hospital, Boston, MA,Juan Pablo de Torres1Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Navarra, Spain
- The BODE index predicts mortality better than 2007 GOLD and GOLD ABCDBy Juan Bertó Botella, Victor Pinto-Plata, Miguel Divo, José María Marín, Bartolome Celli, Ciro Casanova, Carlos Cabrera, Jorge Zagaceta, Pablo Sánchez-Salcedo, Esmeralda López-Zalduendo, Javier Zulueta, Juan Pablo Juan Pablo and Bartolome CelliJuan Bertó Botella1Pulmonology, Clínica Universidad Navarra, Pamplona, Navarra, SpainVictor Pinto-Plata2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Miguel Divo2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,José María Marín2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Bartolome Celli2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Ciro Casanova2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Carlos Cabrera2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Jorge Zagaceta2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Pablo Sánchez-Salcedo1Pulmonology, Clínica Universidad Navarra, Pamplona, Navarra, SpainEsmeralda López-Zalduendo1Pulmonology, Clínica Universidad Navarra, Pamplona, Navarra, SpainJavier Zulueta1Pulmonology, Clínica Universidad Navarra, Pamplona, Navarra, SpainJuan Pablo Juan Pablo1Pulmonology, Clínica Universidad Navarra, Pamplona, Navarra, SpainBartolome Celli2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,
- Chronic obstructive pulmonary disease comorbidities networkBy Miguel J. Divo, Ciro Casanova, Jose M. Marin, Victor M. Pinto-Plata, Juan P. de-Torres, Javier J. Zulueta, Carlos Cabrera, Jorge Zagaceta, Pablo Sanchez-Salcedo, Juan Berto, Rebeca Baz Davila, Ana B. Alcaide, Claudia Cote and Bartolome R. CelliArticle | Published in 2015 in European Respiratory JournalMiguel J. Divo1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USACiro Casanova2Pulmonary Department, Hospital Universitario La Candelaria, Universidad de La Laguna, Santa Cruz de Tenerife, SpainJose M. Marin3Respiratory Service, Hospital Universitario Miguel Servet, Zaragoza, SpainVictor M. Pinto-Plata1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USAJuan P. de-Torres4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainJavier J. Zulueta4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainCarlos Cabrera5Pulmonary Department, Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canarias, SpainJorge Zagaceta4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainPablo Sanchez-Salcedo4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainJuan Berto4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainRebeca Baz Davila2Pulmonary Department, Hospital Universitario La Candelaria, Universidad de La Laguna, Santa Cruz de Tenerife, SpainAna B. Alcaide4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainClaudia Cote6Division of Pulmonary and Critical Care Medicine, The Bay Pines Veterans Affairs Healthcare System, University of South Florida, Tampa, FL, USABartolome R. Celli1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- COPD comorbidities networkBy Miguel J. Divo, Ciro Casanova, Jose M. Marin, Victor M. Pinto-Plata, Juan P. de-Torres, Javier J. Zulueta, Carlos Cabrera, Jorge Zagaceta, Pablo Sanchez-Salcedo, Juan Berto, Rebeca Baz Davila, Ana B. Alcaide, Claudia Cote and Bartolome R. CelliMiguel J. Divo1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USACiro Casanova2Pulmonary Department, Hospital Universitario La Candelaria, Universidad de La Laguna, Santa Cruz de Tenerife, SpainJose M. Marin3Respiratory Service, Hospital Universitario Miguel Servet, Zaragoza, SpainVictor M. Pinto-Plata1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USAJuan P. de-Torres4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainJavier J. Zulueta4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainCarlos Cabrera5Pulmonary Department, Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canarias, SpainJorge Zagaceta4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainPablo Sanchez-Salcedo4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainJuan Berto4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainRebeca Baz Davila2Pulmonary Department, Hospital Universitario La Candelaria, Universidad de La Laguna, Santa Cruz de Tenerife, SpainAna B. Alcaide4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainClaudia Cote6Division of Pulmonary and Critical Care Medicine, The Bay Pines Veterans Affairs Healthcare System, University of South Florida, Tampa, FL, USABartolome R. Celli1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.